Recent IPO activity in 2026 has included dozens of listings, with several small and SPAC-related deals pricing in late September and early October amid ongoing market selectivity. High-profile AI firms such as OpenAI and Anthropic have shifted timelines toward 2027 following confidential filings, citing valuation concerns, model delays, and broader volatility, while Oura postponed its multibillion-dollar offering due to uncertainty. Trader sentiment reflects these delays alongside continued filings and modest proceeds in biotech and infrastructure sectors, with key catalysts including potential Anthropic marketing in Q4 and year-end economic data influencing risk appetite before the December 31, 2026 resolution window.